成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid

(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid Struktur
769167-55-7
CAS-Nr.
769167-55-7
Englisch Name:
(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid
Synonyma:
(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid;(2S)-2-[[(Cyclopentyloxy)carbonyl]amino]-8-nonenoic acid;8-Nonenoic acid, 2-[[(cyclopentyloxy)carbonyl]amino]-, (2S)-
CBNumber:
CB92546749
Summenformel:
C15H25NO4
Molgewicht:
283.36
MOL-Datei:
769167-55-7.mol

(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid Eigenschaften

Siedepunkt:
462.1±44.0 °C(Predicted)
Dichte
1.09
pka
4.01±0.21(Predicted)

Sicherheit

(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hefei Hirisun Pharmatech Co., Ltd
+8615056975894
shawn@hirisunpharm.com CHINA 9911 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49734 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43340 58
Porse Fine Chemical Co.,LTD 20-66003216 18666003216
info@porsefinechemical.com China 2353 62
Shanghai WeiNie Chemical Technology Co., Ltd. 15902145085
657990292@qq.com China 668 50
Hangzhou Molcore Biopharmatech Co.,Ltd 400-711-5280 86-571-81025280
sales@molcore.com China 9967 58
Aikon International Limited 025-58851090 13611564524
lwan@aikonchem.com China 15951 58
Shanghai zhigan biotechnology co., LTD
zhiqianbio@126.com China 19778 58

  • (S)-2-(cyclopentyloxycarbonylaMino)non-8-enoic acid
  • (2S)-2-[[(Cyclopentyloxy)carbonyl]amino]-8-nonenoic acid
  • 8-Nonenoic acid, 2-[[(cyclopentyloxy)carbonyl]amino]-, (2S)-
  • 769167-55-7
Copyright 2019 ? ChemicalBook. All rights reserved